SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-20-085060
Filing Date
2020-03-25
Accepted
2020-03-25 16:06:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1 d899630ds1.htm S-1 199458
2 EX-5.1 d899630dex51.htm EX-5.1 5265
3 EX-23.1 d899630dex231.htm EX-23.1 1904
4 EX-23.2 d899630dex232.htm EX-23.2 1387
5 GRAPHIC g899630g14l88.jpg GRAPHIC 5100
6 GRAPHIC g899630g38b77.jpg GRAPHIC 3534
7 GRAPHIC g899630g42g86.jpg GRAPHIC 26599
8 GRAPHIC g899630g46n47.jpg GRAPHIC 8612
  Complete submission text file 0001193125-20-085060.txt   270087
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-237379 | Film No.: 20742242
SIC: 2834 Pharmaceutical Preparations